New Ocular Telehealth Program Enables Diabetic Retinopathy Screening
Visionix USA and 20/20NOW have launched an ocular telehealth program to enable diabetic retinopathy screening. The new technology will be presented at the American Telemedicine Association (ATA)’s 2024 Nexus Conference and Expo in Arizona in May. Visionix and 20/20NOW will be offering an exclusive exploration on how to get started with telehealth-enabled eye exams at ATA booth #814. One-on-one consultations will be available to learn about:
- How to get started with ocular telehealth
- Establishing a comprehensive screening program
- Exploring visual tools for diabetic retinopathy patient consultations
- Understanding legal, IT and EMR compatibility; as well as ROI, staffing and OPEX considerations
ATA attendees are encouraged to book an appointment.
“The strategic purpose of our technology partnership is to help more providers provide high-quality eye exams to more patients," Matt Vulich, VP National Accounts & Optical Sales at Visionix USA, said in a company news release. "Diabetic retinopathy can have life-changing impact, and we can help more doctors prevent or identify symptoms in its early stages. I am proud to share that our new Ocular Telehealth Program with 20/20NOW offers several Visionix device options—from straightforward retinal screening to comprehensive multimodal screening of eye diseases.”
“If one of your growth objectives is to reach and serve more patients with eye disease, we have a proven process to implement a new ocular telehealth program into your existing infrastructure," Chuck Scott, CEO at 20/20NOW, said in the news release. "We can export completed medical records to your existing EHR or practice management solutions. Using state-of-the-art technology from Visionix, and 20/20NOW’s telehealth technology and professional services platform we can enable any type of medical practice—from rural hospital systems to remote clinics—the ability to provide exams.”